Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes

Published:1998-12 Issue:7 Volume:32 Page:1996-2002
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Azar Rabih R,McKay Raymond G,Thompson Paul D,Hirst Jeffrey A,Mitchell Joseph F,Fram Daniel B,Waters David D,Kiernan Francis J

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction;Frink;Br Heart J,1988

2. Detection of platelet deposition at the site of peripheral balloon angioplasty using indium-111 platelet scintigraphy;Pope;Am J Cardiol,1985

3. Platelet activation during coronary angioplasty in humans;Gasperetti;Circulation,1993

4. Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients;BMJ,1994

5. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty;Schwartz;N Engl J Med,1988

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies: A Prospective and Retrospective View;Current Medicinal Chemistry;2021-02-01

2. Generation and testing of engineered multimeric Fabs of trastuzumab;International Journal of Biological Macromolecules;2020-12

3. Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments;International Journal of Molecular Sciences;2020-08-31

4. Targeted Treatments for Restenosis and Vein Graft Disease;ISRN Vascular Medicine;2012-12-09

5. Hematologic Diseases;Anesthesia and Uncommon Diseases;2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3